Table 2.
Treatment Information of the study patients
| Variable | Proportion, N (%) |
|---|---|
| Diabetes mellitus treatment | |
| Diet-only | 11 (2.9) |
| Oral Glucose-lowering Agents(OGLAs)-only | 262 (68.1) |
| Insulin-only | 66 (17.1) |
| Insulin combined with Oral Glucose-lowering Agents | 46 (12.0) |
| Other co-medications used regularly by the subjects | |
| Anti-platelets | 45 (11.7) |
| Statins | 48 (12.5) |
| Anti-platelets and statins | 108 (28.1) |
| Anti-hypertensive drugs | 295 (76.6) |
| - ACEi/ARBs | 204 (69.0) |
| Frequency of clinic attendance in the last 12 months | |
| 2–3 | 68 (17.7) |
| 4–5 | 292 (75.9) |
| 6 and above | 25 (6.5) |
ACEi Angiotensin Converting Enzyme inhibitors, ARBs Angiotensin Receptor Blockers